Framingham, Mass., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Alira Health, a global advisory and clinical research firm, and Sancare, an award-winning firm whose mission is to harness the potential of hospital data through artificial intelligence (AI), announced the launch of their partnership today. The companies are joining forces to unlock Realli™, a game-changing source of deep hospital Electronic Medical Record (EMR) data linked with claims from an expanding federated network of French hospitals, augmented with AI.

马萨诸塞州弗雷明汉，2024年1月11日（环球通讯社）--全球咨询和临床研究公司Alira Health和获奖公司Sancare今天宣布启动合作关系，Sancare的使命是通过人工智能（AI）利用医院数据的潜力。两家公司正在联手解锁Realli™, 一个改变游戏规则的深度医院电子病历（EMR）数据源，与不断扩大的法国医院联合网络（AI）的索赔相关。

With these new capabilities and the combination of Alira Health’s expertise and extensive industry knowledge and Sancare’s technology and expertise in hospital data systems, the partnership will accelerate innovation by optimizing development and broadening access to healthcare solutions for the benefit of patients and care providers.

凭借这些新功能，结合Alira Health的专业知识和广泛的行业知识，以及Sancare在医院数据系统方面的技术和专业知识，该合作伙伴关系将通过优化开发和扩大医疗保健解决方案的使用范围来加速创新，以造福患者和护理提供者。

“Through the partnership between Alira Health and Sancare, we combine our strengths to create a comprehensive end-to-end service offering that enables data access, analytics, and evidence generation strategy, providing impactful real-world solutions with purpose for patients,” said Jean-François Ricci, Chief Access Officer at Alira Health.

Alira Health首席访问官Jean-François Ricci表示：“通过Alira Health和Sancare之间的合作，我们将优势结合起来，创建全面的端到端服务，实现数据访问、分析和证据生成策略，为患者提供有针对性的有影响力的现实世界解决方案。”。

“Our collaboration creates a central source for study design, data analysis, and communication of actionable insights that address needs for clinical research and market access in France and beyond.” “Our partnership brings new capabilities for healthcare and life sciences organizations, especially for Real-World Evidence (RWE) studies and for data owners,” said Thomas Duval, CEO of Sancare.

“我们的合作为研究设计、数据分析和可行见解的交流创造了一个中心资源，以满足法国及其他国家的临床研究和市场准入需求。”“我们的合作伙伴关系为医疗保健和生命科学组织带来了新的能力，特别是现实世界证据（RWE）研究和数据所有者，”托马斯·杜瓦尔说，Sancare首席执行官。

“By uniting Alira Health’s strengths as a Global Advisory and Contract Research Organization (CRO) with Sancare’s technology, data, and network, we enable important new evidence resources for companies de.

“通过将Alira Health作为全球咨询和合同研究组织（CRO）的优势与Sancare的技术、数据和网络相结合，我们为de公司提供了重要的新证据资源。